NCT07617805
- Conditions
- Biomarker-positive EGFR/HER2- Expressing HNSCC, Carcinoma, Carcinoma, Squamous Cell, +11 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
Clinical trial condition
Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Explore clinical trials studying Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study